Cargando…

Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK

PURPOSE: Treatment guidance for chronic obstructive pulmonary disease (COPD) recommends inhaled corticosteroid (ICS)+long-acting muscarinic antagonist+long-acting β(2)-agonist (LABA) triple therapy for patients who experience recurrent exacerbations, persistent breathlessness, or exercise limitation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quint, Jennifer K, Venerus, Alessandra, O’Leary, Caroline, Myland, Melissa, Holmgren, Ulf, Varghese, Precil, Cabrera, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733404/ https://www.ncbi.nlm.nih.gov/pubmed/33324049 http://dx.doi.org/10.2147/COPD.S278101

Ejemplares similares

Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease
por: Quint, Jennifer K., et al.
Publicado: (2020)

Development and Validation of a Method to Estimate COPD Severity in Multiple Datasets: A Retrospective Study
por: Quint, Jennifer K., et al.
Publicado: (2020)

Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States
por: Schabert, Vernon, et al.
Publicado: (2021)

Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study
por: Jude, Edward B., et al.
Publicado: (2019)

Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN)
por: Jude, Edward B., et al.
Publicado: (2019)

Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK
por: Punekar, Yogesh Suresh, et al.
Publicado: (2015)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
por: Whittaker, Hannah, et al.
Publicado: (2022)

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
por: Brusselle, Guy, et al.
Publicado: (2015)

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
por: Tran, Trung N., et al.
Publicado: (2020)

A Systematic Literature Review of the Humanistic Burden of COPD
por: Hurst, John R, et al.
Publicado: (2021)

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease
por: Cook, Jennifer, et al.
Publicado: (2021)

Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study
por: de Nigris, Enrico, et al.
Publicado: (2022)

An observational cohort study of exercise and education for people with chronic obstructive pulmonary disease not meeting criteria for formal pulmonary rehabilitation programmes
por: Lewis, A, et al.
Publicado: (2019)

Predictors of pulmonary rehabilitation completion in the UK
por: Stone, Philip W., et al.
Publicado: (2021)

Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
por: Schultze, Anna, et al.
Publicado: (2020)

Prescribing Patterns for Long-Acting Inhaled Bronchodilators Among Rural Adults With Chronic Obstructive Pulmonary Disease
por: Brunner, Wendy M., et al.
Publicado: (2022)

Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice
por: Sansbury, Leah B, et al.
Publicado: (2021)

Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD)
por: Shepherd, Charles, et al.
Publicado: (2017)

275. Evaluation of Vancomycin Prescribing Quality in Hospitalized Pediatric Patients
por: Abanyie-Bimbo, Francisca, et al.
Publicado: (2018)

Trends in thyroid hormone prescribing and consumption in the UK
por: Mitchell, Anna L, et al.
Publicado: (2009)

Recent developments in podiatric prescribing in the UK and Australia
por: Gilheany, Mark F, et al.
Publicado: (2009)

Prescribing Errors in UK Hospitals: Problems and Solutions
por: Breckenridge, Ross A.
Publicado: (2012)

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study
por: Evans, Alison, et al.
Publicado: (2020)

Predictors of Referral to Pulmonary Rehabilitation from UK Primary Care
por: Stone, Philip W, et al.
Publicado: (2020)

Three-year incidence of Nd:YAG capsulotomy and posterior capsule opacification and its relationship to monofocal acrylic IOL biomaterial: a UK Real World Evidence study
por: Ursell, Paul G., et al.
Publicado: (2018)

Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes
por: Rothnie, Kieran J., et al.
Publicado: (2016)

UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study
por: Price, David B, et al.
Publicado: (2016)

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK
por: Edwards, Susan C, et al.
Publicado: (2016)

Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence
por: Gao, Yong-Hua, et al.
Publicado: (2021)

Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study
por: Boggon, Rachael, et al.
Publicado: (2013)

Using Big Data to Assess Prescribing Patterns in Greece: The Case of Chronic Obstructive Pulmonary Disease
por: Souliotis, Kyriakos, et al.
Publicado: (2016)

Real-world effects of medications for chronic obstructive pulmonary disease: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results
por: Wing, Kevin, et al.
Publicado: (2018)

Do Not Attempt Resuscitation Order Rates in Hospitalized Patients With Heart Failure, Acute Myocardial Infarction, Chronic Obstructive Pulmonary Disease, and Pneumonia
por: Shore, Supriya, et al.
Publicado: (2022)

Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019
por: Stone, Philip W, et al.
Publicado: (2023)

Non- medical prescribing in Australasia and the UK: the case of podiatry
por: Borthwick, Alan M, et al.
Publicado: (2010)

Teaching safe prescribing to medical students: perspectives in the UK
por: Nazar, Hamde, et al.
Publicado: (2015)

Influences on antidepressant prescribing trends in the UK: 1995–2011
por: Mars, Becky, et al.
Publicado: (2016)

Prescribing issues experienced by people living with phenylketonuria in the UK
por: Ford, Suzanne, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9jabfjeg9qklilhf19krqshs19